Oncology and Cancer Research

Nature Cancer presents a Series of commissioned Reviews on the impact of genomics in guiding cancer diagnosis and treatment, the potential role of emerging technologies, and efforts toward translating new discoveries to the clinic.

An editor-curated selection of some of Nature Communications' recent most exciting papers that significantly move forward the rapid evolving field of cancer research.

The Editors of BMC Medicine are delighted to share with you a selection of key papers that highlight some of the best Oncology research published in the journal.

In this collection BMC Cancer and BMC Biotechnology present the recent advances in the development, applications and safety of CAR-T immunotherapy.

A collection of cancer-related papers published recently in Communications Biology.

Commissioned special issue that highlights the ongoing challenges in metastasis and research being undertaken to more thoroughly understand models of metastasis, disrupt the metastatic cascade, and improve treatment outcomes for patients.

Special issue highlighting the recent efforts in understanding the mechanisms driving cancer evolution, heterogeneity, and metastasis.

Review and research papers covering the unique metabolic properties of cancer cells.

Online collection of key articles published in Oncogene on breast cancer.

Special issue on KRAS - the most frequently mutated human oncogene in cancer.

Special Issue: Six focused mini-reviews that cover specific aspects related to the concept of blood vessel co-option by cancer cells.

Online collection bringing together key articles on this topic from Oncogene, Oncogenesis, British Journal of Cancer, and Blood Cancer Journal

This issue captures the advances in understanding mutational processes and signatures, genome instability, cancer evolution, tumor heterogeneity, immune escape and resistance to therapies.

A collection describing advances using genomic approaches toward characterizing the immune system in the tumor microenvironment, anti-tumor immune responses, and immunotherapeutic targeting.